What it is: AVIIR™ is a three-ingredient concentrated botanical antiviral and antimicrobial formula from Panaxea International, delivering three standardized isolates — Andrographis paniculata (standardized to 95% Andrographolide), Taraxacum officinale (standardized to 20% Taraxasterol), and Lonicera japonica (standardized to 25% Chlorogenic acid) — in a 500 mg vegetable capsule. Each ingredient is standardized to its primary bioactive at concentrations well above typical herbal extract thresholds. Manufactured to Australian Pharmaceutical GMP standards for exclusive practitioner-directed use. How it works: Andrographolide (95% standardization) drives the formula's primary antiviral and antibacterial activity — inhibiting NF-κB-mediated inflammatory cytokine production, blocking viral replication through protease inhibition, and demonstrating activity against drug-resistant Gram-negative bacteria. Taraxasterol (20% standardization) delivers direct antiviral, hepatoprotective, and immunomodulatory activity through triterpene-mediated mechanisms — supporting liver detoxification of pathogenic burden and modulating innate immune responses. Chlorogenic acid from Lonicera japonica (25% standardization) provides complementary antiviral activity against influenza and respiratory viral pathogens through viral replication inhibition, alongside antibacterial, antipyretic, and anti-inflammatory activity through cyclooxygenase pathway modulation. Together the three standardized isolates address bacterial, viral, and fungal pathogen burden through overlapping and non-redundant mechanisms. When to use it: Indicated for adults requiring broad-spectrum botanical antiviral, antibacterial, and immune support — including upper respiratory viral infections, persistent or drug-resistant bacterial infections, and seasonal immune challenges. Two to three capsules two to three times daily, or three capsules three times daily for one month in acute or persistent presentations. Contraindicated during pregnancy and breastfeeding.